Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate OPKO Health, Inc. before investing.

In this article, we go over a few key elements for understanding OPKO Health, Inc.’s stock price such as:

• OPKO Health, Inc.’s current stock price and volume
• Why OPKO Health, Inc.’s stock price changed recently
• Upgrades and downgrades for OPK from analysts
• OPK’s stock price momentum as measured by its relative strength

About OPKO Health, Inc. (OPK)

Before we jump into OPKO Health, Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

OPKO Health, Inc. operates as a healthcare company, in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company operates in two segments, Pharmaceutical and Diagnostics. The Pharmaceutical segment develops MDX2001, a tetra-specific antibody targeting several types of solid tumors in Phase 1 clinical trials; MDX2003, a tetra-specific antibody targeting two antigens for hematological tumors in Phase 1 clinical trials; and MDX2004, a trispecific immune modulator to rebuild and sustain the patient's own immune system. This segment also engages in the development of Epstein Barr Virus vaccine; Rayaldee, a patented extended-release product for oral administration containing 30 mcg of a prohormone; OPK-88006 oral and injectable product to regulate blood glucose and reduce body weight; NGENLA, recombinant human growth hormone product developed for the long-term treatment of pediatric patients with growth hormone deficiency. The Diagnostics segment offers laboratory testing services, such as detection, diagnosis, evaluation, monitoring, and treatment of diseases, as well as esoteric testing, molecular diagnostics, anatomical pathology, genetics, women’s health, and correctional healthcare under the BioReference brand; and 4Kscore test. OPKO Health, Inc. was founded in 2006 and is headquartered in Miami, Florida.

Want to learn more about OPKO Health, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about OPKO Health, Inc..

OPKO Health, Inc.’s Stock Price as of Market Close

As of July 31, 2026, 4:00 PM, CST, OPKO Health, Inc.’s stock price was $1.320.

OPKO Health, Inc. is down 1.12% from its previous closing price of $1.335.

During the last market session, OPKO Health, Inc.’s stock traded between $1.305 and $1.350. Currently, there are approximately 755.27 million shares outstanding for OPKO Health, Inc..

OPKO Health, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

OPKO Health, Inc. Stock Price History

OPKO Health, Inc.’s (OPK) price is currently down 12% so far this month.

During the month of July, OPKO Health, Inc.’s stock price has reached a high of $1.730 and a low of $1.165.

Over the last year, OPKO Health, Inc. has hit prices as high as $1.730 and as low as $0.977. Year to date, OPKO Health, Inc.’s stock is up 4.76%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused OPKO Health, Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 31, 2026, there were 0 analysts who downgraded OPKO Health, Inc.’s stock and 1 analyst who upgraded over the last month.

Additionally, you'll want to evaluate OPKO Health, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on OPKO Health, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

OPKO Health, Inc.’s current valuation based on AAII’s Value Grade is a A, which means it is considered to be Deep Value.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about OPKO Health, Inc. (OPK) by visiting AAII Stock Evaluator.

Relative Price Strength of OPKO Health, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 31, 2026, OPKO Health, Inc. has a weighted four-quarter relative price strength of 1.13%, which translates to a Momentum Score of 57 and is considered to be Average.

Want to learn more about how OPKO Health, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

OPKO Health, Inc. Stock Price: Bottom Line

As of July 31, 2026, OPKO Health, Inc.’s stock price is $1.320, which is down 1.12% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like OPKO Health, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.